Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106977470B enables green synthesis of 2-iminothiazoline derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114920616B reveals a metal-free amidine synthesis route offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability for global buyers.
Patent CN111909038A introduces a safe, low-pressure Schiff base catalyzed route for phenylenediamine, offering significant cost and safety advantages over traditional nitration.
Patent CN117964512B reveals a low-toxicity synthesis route for N,N-dimethyl-3-methoxypropionamide using Lewis acid catalysts, offering significant supply chain and cost advantages for industrial buyers.
Patent CN113105354B enables catalyst-free synthesis ensuring high purity and cost efficiency for reliable pharmaceutical intermediates supply chains globally.
Novel acid-catalyzed method reduces aldehyde usage and eliminates metal catalysts for cost-effective manufacturing.
Patent CN104311377B reveals copper-catalyzed biphenyl synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107721969B reveals a safe, high-yield route for chiral TADDOLs using isopropyl magnesium bromide, offering significant cost reduction and supply chain reliability.
Patent CN111732536A reveals a catalyst-free, solvent-free thermal amination route for aminopyridines, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN108017593A reveals a safer route for 1-oxo-4-5-diazepane. Enhance supply chain stability and reduce manufacturing costs for herbicide intermediates.
Patent CN105884570B enables mild arylation. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN110229180B reveals air-tolerant manganese catalysis for selective alkenyl silane production, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN111138299A details a solvent-free method for triarylmethanes. Offers high purity, reduced waste, and scalable production for pharma intermediates.
Patent CN110372633B details a transition-metal-free reduction method using NaBEt3H, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN114522738B enables efficient 1,3-propanediol synthesis via Cu-catalysis. Delivers supply chain stability and cost reduction in polymer intermediate manufacturing.
Discover the novel synthesis of 6-fluoro-2,4-diaminonitrobenzene via mild ammoniation. This patent-backed route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104130092B details a novel one-step reductive coupling method. This breakthrough offers significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Novel Ni(II)-SNC catalyst enables high-yield sulfide oxidation under mild conditions, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN112921345B reveals a green electrochemical route for phosphorothioates, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN116284117A introduces a green electrochemical route for thiophosphoramides, offering cost reduction and high purity for pharmaceutical and agrochemical manufacturing.